Replimune's Konstantinos Xynos sells 16,198 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Replimune Group, Inc. Chief Medical Officer Konstantinos Xynos reported a sale of 16,198 shares on November 16, 2026, at a weighted average sale price of $21.60 per share. The shares were sold to cover tax withholding obligations connected with vesting of his restricted stock units under an irrevocable sell-to-cover provision in the award agreements; the transaction was not discretionary. The reported sale prices ranged from $21.58 to $21.60 per share. Xynos held 208,017 shares directly after the transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 16,198 | $21.60 | $350K |
Footnotes (2)
- F1. Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the vesting of the Reporting Person's Restricted Stock Units (the "RSUs"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person.
- F2. The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $21.58 to $21.60 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range.
Key Figures
Key Terms
Restricted Stock Units financial
weighted average price financial
sell to cover financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.